Mangoceuticals, Inc. Common Stock (MGRX)vsTempus AI, Inc. Class A Common Stock (TEM)
MGRX
Mangoceuticals, Inc. Common Stock
$0.40
+4.62%
HEALTHCARE · Cap: $8.42M
TEM
Tempus AI, Inc. Class A Common Stock
$59.01
+0.46%
HEALTHCARE · Cap: $11.66B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 454178% more annual revenue ($1.43B vs $315,230). MGRX leads profitability with a 0.0% profit margin vs -17.8%. TEM earns a higher WallStSmart Score of 28/100 (F).
MGRX
Avoid23
out of 100
Grade: F
TEM
Avoid28
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 21.6% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
Trading at 23.9x book value
ROE of -57.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.
Key Dynamics to Monitor
MGRX profiles as a value stock while TEM is a growth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.72 — expect wider price swings.
TEM is growing revenue faster at 21.6% — sustainability is the question.
MGRX generates stronger free cash flow (-260,506), providing more financial flexibility.
Bottom Line
TEM scores higher overall (28/100 vs 23/100) and 21.6% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?